logo
Book a meeting
AdipoPharma SAS

Adipo Pharma Sas

Biotechnology, 701 Lee Rd Ste 210, Strasbourg, Pennsylvania, 19087, United States, 1-10 Employees

adipopharma.com

  • LinkedIn

phone no Phone Number: +12*********

Who is ADIPOPHARMA SAS

AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and m...

Read More

lock icon Get Full Access
map
  • 701 Lee Rd Ste 210, Strasbourg, Pennsylvania, 19087, United States Headquarters: 701 Lee Rd Ste 210, Strasbourg, Pennsylvania, 19087, United States
  • 2022 Date Founded: 2022
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ADIPOPHARMA SAS

AdipoPharma SAS Org Chart and Mapping

Employees
James Nolan

James Nolan

Chairmen of the Board / Chief Business Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for AdipoPharma SAS
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding AdipoPharma SAS

Answer: AdipoPharma SAS's headquarters are located at 701 Lee Rd Ste 210, Strasbourg, Pennsylvania, 19087, United States

Answer: AdipoPharma SAS's phone number is +12*********

Answer: AdipoPharma SAS's official website is https://adipopharma.com

Answer: AdipoPharma SAS's revenue is $10 Million to $25 Million

Answer: AdipoPharma SAS's SIC: 8731

Answer: AdipoPharma SAS's NAICS: 541714

Answer: AdipoPharma SAS has 1-10 employees

Answer: AdipoPharma SAS is in Biotechnology

Answer: AdipoPharma SAS contact info: Phone number: +12********* Website: https://adipopharma.com

Answer: AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access